Form 4 for LION Lionsgate Studios Corp.
Accepted 2025-12-02 00:00:00 ET · period of report 2025-11-28 · accession 0001193125-25-305411 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-02 | 2025-11-28 | LION | RACHESKY MARK H MD | Dir, 10% | A - Grant | $7.46 | +30.3K | 20.1K | New | +$226.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-11-28 | A | A | 10,188 | $7.46 | 251,488 | D | — | — | (F1) Director fees granted in Common Shares of the Issuer. |
| 2 | Common | Common Shares | 2025-11-28 | A | A | 20,107 | $7.46 | 20,107 | D | — | — | (F2) These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one remaining equal annual installment on November 28, 2026. |